tirzepatide kidney disease (Zepbound) showed improved function in obese patients with both chronic kidney and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https SURPASS-4: Tirzepatide slows kidney disease

These receptors play critical roles in regulating appetite and energy expenditure, making them prime targets for a comprehensive obesity treatment

Its too early to know how much the pill will cost or how insurance companies might cover it, a Lilly spokesperson said

S., Lam, C

Loss of Lean Muscle Mass Rapid weight loss associated with GLP-1 therapy typically includes a proportion of skeletal muscle mass, which can impair basal metabolic rate, physical function, and glucose disposal

The National Association of Boards of Pharmacy (NABP) warns that over 40,000 online pharmacies operate illegally or without proper recommendations

Follow the product-specific storage instructions for how long the pen can remain at room temperature if needed